Explainers
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Inoviq.
RELATED STOCKHEAD STORIES
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Merchant Group’s Andrew Chapman has his eye on these diagnostic biotech stocks
Health & Biotech
ASX Health Stocks: Imricor jumps 13pc after funding deal; Louie the Beagle passes 1-year mark taking PharmAust’s drug
Health & Biotech
These were the best ASX biotechs as Health Care sprang back to life in FY23
Health & Biotech
Check Up: Diet Coke put on notice as WHO labels artificial sweetener aspartame ‘possibly carcinogenic’
News
ASX Small Caps and IPO Weekly Wrap: 30 hours of hot ASX action and we’re right back where we started
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer test
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Shopping centres, diggers and banks drive local market +0.65% against overseas tide
News
In Case You Missed It: Lithium hits and a high accuracy breast cancer test
News
ASX Small Caps Lunch Wrap: Who’s ready for a fresh round of lab-meat hysteria this week?
Health & Biotech
ASX Health stocks: INOVIQ soars 44pc on clinical data for breast cancer test
Health & Biotech
ASX Health Stocks: INOVIQ says its breast cancer technology beats currently available tests
News
Top 10 at 10: These ASX stocks are building up a head of steam in early trade
Health & Biotech
ASX Health Stocks: Inoviq and Doctor Care Anywhere surge over 20pc; CSL welcomes new CEO
News
Top 10 at 10: ASX stocks rocket on positive clinical studies, shallow gold, and high grade niobium
Health & Biotech
